Skip to content

Effect of multicomponent rehabilitation on fall risk reduction in elderly patient hospitalized with parkinsonism and peripheral neuropathy

Effect of multicomponent rehabilitation on fall risk reduction in elderly participant hospitalized with parkinsonism and peripheral neuropathy - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101112
Enrollment
50
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G218- Other secondary parkinsonism Health Condition 2: G20- Parkinsons disease Health Condition 3: G63- Polyneuropathy in diseases classified elsewhere Health Condition 4: G219- Secondary parkinsonism, unspecified Health Condition 5: G214- Vascular parkinsonism

Interventions

Intervention1: MULTICOMPONENT REHABILITATION.: PHYSIOTHERAPY OPTIMISING PARKINSONS MEDICATIONS(AS PER SENIOR CONSULTANT /TREATING DOCTOR ORDERS) SUPPLIMENTNG VITAMIN B12(1000mcg/day) AND VIT D(2000U/d

Sponsors

DR ABHISHEK B SANNATANGIYAVAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients already diagnosed with parkinsonism and peripheral neuropathy. 2. Age more than or equal to 60 years. 3. Who are able to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with major neuro cognitive disorder. 2. Patients with drug induced parkinsonism. 3. Patients of stage Parkinsonism of Hoehn and Yahr classification. 4. Patients who are of multi organ failure and hypoxia. 5. Patients with acute illness and acute infection. 6 Patients of chronic kidney disease on dialysis. 7. Patients who are exposed to neurotoxin or chemotherapy.

Design outcomes

Primary

MeasureTime frame
1. Reduction in fall risk in elderly. Timepoint: 5days

Secondary

MeasureTime frame
2. Improving the balance in elderly. 3. Efficacy of etiology based therapy.Timepoint: AT DAY 5 AND AT THE TIME OF DISCHARGE OF THE PATIENT.

Countries

India

Contacts

Public ContactDR ABHISHEK B SANNATANGIYAVAR

YENEPOYA MEDICAL COLLEGE AND HOSPITAL

prabha.raghuveer@gmail.com9880991290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026